Detailed information for compound 512897

Basic information

Technical information
  • TDR Targets ID: 512897
  • Name: 3-[(E)-(9-methoxy-6-piperazin-1-ylindeno[1,2- c]quinolin-11-ylidene)amino]oxy-N,N-dimethylp ropan-1-amine
  • MW: 445.557 | Formula: C26H31N5O2
  • H donors: 1 H acceptors: 1 LogP: 4.08 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc2c(c1)/C(=N\OCCCN(C)C)/c1c2c(nc2c1cccc2)N1CCNCC1
  • InChi: 1S/C26H31N5O2/c1-30(2)13-6-16-33-29-25-21-17-18(32-3)9-10-19(21)24-23(25)20-7-4-5-8-22(20)28-26(24)31-14-11-27-12-15-31/h4-5,7-10,17,27H,6,11-16H2,1-3H3/b29-25+
  • InChiKey: PNUJPTIHYOIYLV-XLVZBRSZSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 3-[(E)-(9-methoxy-6-piperazin-1-yl-indeno[1,2-c]quinolin-11-ylidene)amino]oxy-N,N-dimethyl-propan-1-amine
  • 3-[(E)-[9-methoxy-6-(1-piperazinyl)-11-indeno[1,2-c]quinolinylidene]amino]oxy-N,N-dimethyl-1-propanamine
  • 3-[(E)-(9-methoxy-6-piperazino-indeno[1,2-c]quinolin-11-ylidene)amino]oxypropyl-dimethyl-amine

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens topoisomerase (DNA) I Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Leishmania braziliensis DNA topoisomerase IB, large subunit Get druggable targets OG5_127702 All targets in OG5_127702
Neospora caninum hypothetical protein Get druggable targets OG5_127702 All targets in OG5_127702
Leishmania mexicana DNA topoisomerase IB, large subunit Get druggable targets OG5_127702 All targets in OG5_127702
Trypanosoma brucei DNA topoisomerase IB, large subunit Get druggable targets OG5_127702 All targets in OG5_127702
Leishmania donovani DNA topoisomerase IB, large subunit Get druggable targets OG5_127702 All targets in OG5_127702
Plasmodium knowlesi topoisomerase I, putative Get druggable targets OG5_127702 All targets in OG5_127702
Plasmodium berghei topoisomerase I, putative Get druggable targets OG5_127702 All targets in OG5_127702
Trypanosoma brucei gambiense DNA topoisomerase IB, large subunit, putative Get druggable targets OG5_127702 All targets in OG5_127702
Brugia malayi DNA topoisomerase I Get druggable targets OG5_127702 All targets in OG5_127702
Plasmodium yoelii Eukaryotic DNA topoisomerase I, DNA binding, putative Get druggable targets OG5_127702 All targets in OG5_127702
Echinococcus multilocularis DNA topoisomerase 1 Get druggable targets OG5_127702 All targets in OG5_127702
Candida albicans likely DNA topoisomerase I similar to S. cerevisiae TOP1 (YOL006C) Get druggable targets OG5_127702 All targets in OG5_127702
Cryptosporidium parvum eukaryotic DNA topoisomerase I Get druggable targets OG5_127702 All targets in OG5_127702
Trypanosoma cruzi DNA topoisomerase IB, large subunit, putative Get druggable targets OG5_127702 All targets in OG5_127702
Babesia bovis DNA topoisomerase Get druggable targets OG5_127702 All targets in OG5_127702
Leishmania major DNA topoisomerase IB, large subunit Get druggable targets OG5_127702 All targets in OG5_127702
Schistosoma mansoni DNA topoisomerase type I Get druggable targets OG5_127702 All targets in OG5_127702
Candida albicans likely DNA topoisomerase I similar to S. cerevisiae TOP1 (YOL006C) Get druggable targets OG5_127702 All targets in OG5_127702
Toxoplasma gondii DNA topoisomerase I, putative Get druggable targets OG5_127702 All targets in OG5_127702
Schistosoma japonicum IPR011010,DNA breaking-rejoining enzyme, catalytic core,domain-containing Get druggable targets OG5_127702 All targets in OG5_127702
Schistosoma japonicum ko:K03163 DNA topoisomerase I, putative Get druggable targets OG5_127702 All targets in OG5_127702
Cryptosporidium hominis DNA topoisomerase I Get druggable targets OG5_127702 All targets in OG5_127702
Plasmodium falciparum topoisomerase I Get druggable targets OG5_127702 All targets in OG5_127702
Echinococcus granulosus DNA topoisomerase 1 Get druggable targets OG5_127702 All targets in OG5_127702
Schistosoma mansoni DNA topoisomerase type I Get druggable targets OG5_127702 All targets in OG5_127702
Theileria parva DNA topoisomerase I, putative Get druggable targets OG5_127702 All targets in OG5_127702
Schistosoma mansoni DNA topoisomerase type I Get druggable targets OG5_127702 All targets in OG5_127702
Loa Loa (eye worm) DNA topoisomerase I Get druggable targets OG5_127702 All targets in OG5_127702
Leishmania infantum DNA topoisomerase IB, large subunit Get druggable targets OG5_127702 All targets in OG5_127702
Plasmodium vivax topoisomerase I, putative Get druggable targets OG5_127702 All targets in OG5_127702

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0031 0.0265 0.0979
Echinococcus multilocularis ubiquitin specific protease 41 0.0043 0.0412 0.0412
Mycobacterium tuberculosis Probable hydrolase 0.0042 0.0398 0.0793
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0023 0.0153 0.0153
Schistosoma mansoni ubiquitin-specific peptidase 2 (C19 family) 0.0043 0.0412 0.0378
Trypanosoma brucei glucosidase, putative 0.0042 0.04 0.1735
Schistosoma mansoni cpg binding protein 0.0035 0.0315 0.0281
Loa Loa (eye worm) glycosyl hydrolase family 31 protein 0.019 0.2261 0.8337
Echinococcus multilocularis cytoplasmic intermediate filament protein 0.0015 0.0061 0.0061
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0153 0.0455
Toxoplasma gondii histone lysine methyltransferase SET1 0.0064 0.0668 0.1734
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Mycobacterium leprae Probable lipase LipE 0.0042 0.0398 0.5
Loa Loa (eye worm) hypothetical protein 0.0042 0.0398 0.1468
Trypanosoma cruzi DNA polymerase eta, putative 0.0052 0.0527 0.238
Echinococcus multilocularis dna polymerase kappa 0.0023 0.0153 0.0153
Leishmania major hypothetical protein, conserved 0.0029 0.024 0.0893
Schistosoma mansoni cpg binding protein 0.0034 0.0291 0.0257
Toxoplasma gondii ImpB/MucB/SamB family protein 0.0037 0.0331 0.0371
Mycobacterium tuberculosis Conserved protein 0.0042 0.0398 0.0793
Echinococcus multilocularis beta LACTamase domain containing family member 0.0042 0.0398 0.0398
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Toxoplasma gondii ABC1 family protein 0.0042 0.0398 0.0641
Onchocerca volvulus 0.0031 0.0265 0.1672
Brugia malayi ImpB/MucB/SamB family protein 0.0052 0.0527 0.1737
Onchocerca volvulus 0.0042 0.0398 0.2791
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0023 0.0153 0.0444
Loa Loa (eye worm) hypothetical protein 0.0031 0.0258 0.0952
Trichomonas vaginalis alpha-glucosidase, putative 0.0042 0.04 0.9648
Brugia malayi ImpB/MucB/SamB family protein 0.0023 0.0153 0.0324
Echinococcus multilocularis lamin dm0 0.0031 0.0265 0.0265
Mycobacterium leprae conserved hypothetical protein 0.0042 0.0398 0.5
Trichomonas vaginalis D-aminoacylase, putative 0.0042 0.0398 0.9585
Loa Loa (eye worm) beta-lactamase 0.0042 0.0398 0.1468
Plasmodium falciparum topoisomerase I 0.0226 0.2712 1
Echinococcus multilocularis lysosomal alpha glucosidase 0.019 0.2261 0.2261
Trichomonas vaginalis D-aminoacylase, putative 0.0042 0.0398 0.9585
Loa Loa (eye worm) hypothetical protein 0.0015 0.0061 0.0223
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Trichomonas vaginalis Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase 0.0043 0.0412 1
Loa Loa (eye worm) intermediate filament protein 0.0031 0.0265 0.0979
Onchocerca volvulus 0.0034 0.0291 0.1889
Toxoplasma gondii glycosyl hydrolase, family 31 protein 0.0042 0.04 0.065
Leishmania major DNA polymerase eta, putative 0.0052 0.0527 0.238
Schistosoma mansoni lamin 0.0031 0.0265 0.0231
Loa Loa (eye worm) hypothetical protein 0.0042 0.0398 0.1468
Echinococcus multilocularis Ataxin 2, N terminal,domain containing protein 0.0013 0.0036 0.0036
Echinococcus multilocularis Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 0.0043 0.0412 0.0412
Trichomonas vaginalis penicillin-binding protein, putative 0.0042 0.0398 0.9585
Echinococcus granulosus ubiquitin carboxyl terminal hydrolase 8 0.0043 0.0412 0.0412
Trypanosoma brucei glycosyl hydrolase-like protein 0.0016 0.0067 0.0012
Trichomonas vaginalis neutral alpha-glucosidase ab precursor, putative 0.0042 0.04 0.9648
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.0042 0.0398 0.1251
Brugia malayi DNA topoisomerase I 0.0226 0.2712 1
Trypanosoma cruzi hypothetical protein, conserved 0.0042 0.0398 0.1714
Schistosoma mansoni terminal deoxycytidyl transferase 0.0023 0.0153 0.0118
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0153 0.0444
Trichomonas vaginalis sucrase-isomaltase, putative 0.0042 0.04 0.9648
Giardia lamblia Ubiquitin carboxyl-terminal hydrolase 4 0.0043 0.0412 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0153 0.0444
Brugia malayi cytoplasmic intermediate filament protein 0.0017 0.0082 0.0054
Trypanosoma cruzi hypothetical protein, conserved 0.0042 0.04 0.1725
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0042 0.0398 0.0364
Echinococcus granulosus lamin 0.0031 0.0265 0.0265
Toxoplasma gondii DNA topoisomerase I, putative 0.0226 0.2712 1
Trypanosoma cruzi DNA polymerase eta, putative 0.0037 0.0331 0.1368
Plasmodium vivax hypothetical protein, conserved 0.0042 0.0398 0.0641
Trypanosoma cruzi hypothetical protein, conserved 0.0042 0.0398 0.1714
Loa Loa (eye worm) hypothetical protein 0.0052 0.0527 0.1942
Brugia malayi Glycosyl hydrolases family 31 protein 0.0042 0.04 0.1259
Onchocerca volvulus 0.0031 0.0265 0.1672
Schistosoma mansoni intermediate filament proteins 0.0031 0.0265 0.0231
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.0042 0.0398 0.1468
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Echinococcus multilocularis musashi 0.0031 0.0265 0.0265
Onchocerca volvulus 0.011 0.1253 1
Trypanosoma brucei ubiquitin carboxyl-terminal hydrolase, putative 0.0043 0.0412 0.1798
Trichomonas vaginalis alpha-glucosidase, putative 0.0042 0.04 0.9648
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0023 0.0153 0.0153
Brugia malayi beta-lactamase 0.0042 0.0398 0.1251
Loa Loa (eye worm) intermediate filament tail domain-containing protein 0.0031 0.0265 0.0979
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0153 0.0455
Echinococcus granulosus neutral alpha glucosidase AB 0.0042 0.04 0.04
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0043 0.0412 0.1788
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0153 0.0444
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Echinococcus granulosus Ataxin 2 N terminaldomain containing protein 0.0013 0.0036 0.0036
Echinococcus multilocularis lamin 0.0031 0.0265 0.0265
Trypanosoma cruzi DNA topoisomerase type IB small subunit, putative 0.0057 0.0584 0.2676
Brugia malayi beta-lactamase family protein 0.0042 0.0398 0.1251
Mycobacterium tuberculosis Possible conserved lipoprotein LpqK 0.0042 0.0398 0.0793
Trichomonas vaginalis D-aminoacylase, putative 0.0042 0.0398 0.9585
Trichomonas vaginalis alpha-glucosidase, putative 0.0042 0.04 0.9648
Echinococcus multilocularis DNA topoisomerase 1 0.0226 0.2712 0.2712
Schistosoma mansoni alpha-glucosidase 0.0164 0.1928 0.1899
Trichomonas vaginalis esterase, putative 0.0042 0.0398 0.9585
Trichomonas vaginalis neutral alpha-glucosidase ab precursor, putative 0.0042 0.04 0.9648
Loa Loa (eye worm) DNA topoisomerase I 0.0226 0.2712 1
Entamoeba histolytica deoxycytidyl transferase, putative 0.0023 0.0153 0.2481
Loa Loa (eye worm) cytoplasmic intermediate filament protein 0.0017 0.0082 0.0301
Trichomonas vaginalis maltase-glucoamylase, putative 0.0042 0.04 0.9648
Mycobacterium ulcerans fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE 0.0042 0.0398 1
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0023 0.0153 0.2481
Echinococcus multilocularis dnaJ subfamily B 0.0478 0.5874 0.5874
Entamoeba histolytica glycosyl hydrolase, family 31 protein 0.0042 0.04 0.9648
Echinococcus granulosus DNA topoisomerase 1 0.0226 0.2712 0.2712
Echinococcus multilocularis microtubule associated protein 2 0.0806 1 1
Schistosoma mansoni lamin 0.0031 0.0265 0.0231
Trypanosoma brucei hypothetical protein, conserved 0.0042 0.0398 0.1723
Schistosoma mansoni DNA topoisomerase type I 0.0226 0.2712 0.2686
Mycobacterium tuberculosis Conserved protein 0.0042 0.0398 0.0793
Mycobacterium tuberculosis Probable lipase LipE 0.0042 0.0398 0.0793
Schistosoma mansoni cpg binding protein 0.0035 0.0315 0.0281
Echinococcus multilocularis lysosomal alpha glucosidase 0.019 0.2261 0.2261
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Trichomonas vaginalis alpha-glucosidase, putative 0.0042 0.04 0.9648
Echinococcus granulosus dnaJ subfamily B 0.0478 0.5874 0.5874
Trypanosoma brucei DNA polymerase eta, putative 0.0052 0.0527 0.2389
Trichomonas vaginalis Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase 0.0043 0.0412 1
Echinococcus granulosus beta LACTamase domain containing family member 0.0042 0.0398 0.0398
Mycobacterium ulcerans beta-lactamase 0.0042 0.0398 1
Trypanosoma brucei unspecified product 0.0023 0.0153 0.0455
Trypanosoma brucei DNA topoisomerase type IB small subunit 0.0057 0.0584 0.2684
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Loa Loa (eye worm) hypothetical protein 0.0042 0.0398 0.1468
Leishmania major ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative 0.0043 0.0412 0.1788
Brugia malayi hypothetical protein 0.0029 0.024 0.0652
Echinococcus granulosus ubiquitin specific protease 41 0.0043 0.0412 0.0412
Schistosoma mansoni hypothetical protein 0.0478 0.5874 0.5859
Echinococcus granulosus dna polymerase eta 0.0052 0.0527 0.0527
Schistosoma mansoni DNA topoisomerase type I 0.0169 0.1998 0.197
Loa Loa (eye worm) glycosyl hydrolase family 31 protein 0.0042 0.04 0.1476
Trichomonas vaginalis penicillin-binding protein, putative 0.0042 0.0398 0.9585
Loa Loa (eye worm) hypothetical protein 0.0029 0.024 0.0883
Schistosoma mansoni DNA topoisomerase type I 0.0169 0.1998 0.197
Schistosoma mansoni ubiquitin-specific peptidase 8 (C19 family) 0.0043 0.0412 0.0378
Loa Loa (eye worm) hypothetical protein 0.0042 0.0398 0.1468
Echinococcus granulosus cpg binding protein 0.0035 0.0315 0.0315
Plasmodium vivax topoisomerase I, putative 0.0226 0.2712 1
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0071 0.0764 0.0731
Brugia malayi CXXC zinc finger family protein 0.0034 0.0291 0.0847
Loa Loa (eye worm) hypothetical protein 0.0015 0.0053 0.0197
Brugia malayi Glycosyl hydrolases family 31 protein 0.019 0.2261 0.8295
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0023 0.0153 0.0118
Schistosoma mansoni alpha-glucosidase 0.0164 0.1928 0.1899
Trichomonas vaginalis DNA polymerase eta, putative 0.0023 0.0153 0.2481
Echinococcus multilocularis ubiquitin carboxyl terminal hydrolase 8 0.0043 0.0412 0.0412
Trypanosoma cruzi PAB1-binding protein , putative 0.0029 0.024 0.0893
Trypanosoma cruzi PAB1-binding protein , putative 0.0029 0.024 0.0893
Loa Loa (eye worm) ImpB/MucB/SamB family protein 0.0023 0.0153 0.0564
Loa Loa (eye worm) hypothetical protein 0.0015 0.0053 0.0197
Loa Loa (eye worm) hypothetical protein 0.0042 0.0398 0.1468
Loa Loa (eye worm) hypothetical protein 0.0016 0.0067 0.0248
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.0153 0.0444
Mycobacterium tuberculosis Conserved protein 0.0042 0.0398 0.0793
Echinococcus granulosus dna polymerase kappa 0.0023 0.0153 0.0153
Mycobacterium tuberculosis Probable conserved lipoprotein 0.0042 0.0398 0.0793
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0269 0.3246 1
Echinococcus multilocularis cpg binding protein 0.0035 0.0315 0.0315
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0042 0.0398 0.0364
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Loa Loa (eye worm) CXXC zinc finger family protein 0.0034 0.0291 0.1073
Brugia malayi Intermediate filament tail domain containing protein 0.0031 0.0265 0.0749
Onchocerca volvulus 0.0042 0.0398 0.2791
Leishmania major alpha glucosidase II subunit, putative 0.0042 0.04 0.1725
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0043 0.0412 0.1788
Entamoeba histolytica glycosyl hydrolase, family 31 protein 0.0042 0.04 0.9648
Mycobacterium ulcerans hypothetical protein 0.0042 0.0398 1
Mycobacterium ulcerans lipase LipD 0.0042 0.0398 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.0153 0.0455
Echinococcus granulosus Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 0.0043 0.0412 0.0412
Brugia malayi intermediate filament protein 0.0031 0.0265 0.0749
Echinococcus granulosus lysosomal alpha glucosidase 0.019 0.2261 0.2261
Entamoeba histolytica ubiquitin carboxyl-terminal hydrolase domain containing protein 0.0043 0.0412 1
Onchocerca volvulus 0.0042 0.0398 0.2791
Trypanosoma brucei DNA topoisomerase IB, large subunit 0.0169 0.1998 1
Echinococcus granulosus lamin dm0 0.0031 0.0265 0.0265
Schistosoma mansoni microtubule-associated protein tau 0.0806 1 1
Loa Loa (eye worm) hypothetical protein 0.0043 0.0412 0.1521
Echinococcus granulosus intermediate filament protein 0.0031 0.0265 0.0265
Trypanosoma cruzi DNA topoisomerase IB, large subunit, putative 0.0169 0.1998 1
Leishmania major DNA topoisomerase IB, large subunit 0.0169 0.1998 1
Brugia malayi Ubiquitin carboxyl-terminal hydrolase family protein 0.0043 0.0412 0.1305
Schistosoma mansoni DNA polymerase eta 0.0052 0.0527 0.0493
Echinococcus multilocularis neutral alpha glucosidase AB 0.0042 0.04 0.04
Brugia malayi beta-lactamase family protein 0.0042 0.0398 0.1251
Loa Loa (eye worm) hypothetical protein 0.0042 0.0398 0.1468
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.0153 0.0455
Leishmania major DNA topoisomerase type IB small subunit 0.0057 0.0584 0.2676
Leishmania major hypothetical protein, conserved 0.0042 0.0398 0.1714
Trichomonas vaginalis conserved hypothetical protein 0.0043 0.0412 1
Mycobacterium tuberculosis Probable lipase LipD 0.0042 0.0398 0.0793
Leishmania major DNA polymerase kappa, putative 0.0023 0.0153 0.0444
Brugia malayi hypothetical protein 0.0019 0.0108 0.0156
Trichomonas vaginalis alpha-glucosidase, putative 0.0042 0.04 0.9648
Mycobacterium tuberculosis Probable esterase/lipase LipP 0.0042 0.0398 0.0793
Trypanosoma brucei PAB1-binding protein , putative 0.0029 0.024 0.0903
Mycobacterium tuberculosis Probable esterase LipL 0.0042 0.0398 0.0793
Mycobacterium ulcerans esterase/lipase LipP 0.0042 0.0398 1
Echinococcus granulosus cytoplasmic intermediate filament protein 0.0015 0.0061 0.0061
Leishmania major DNA polymerase eta, putative 0.0037 0.0331 0.1368
Trypanosoma cruzi hypothetical protein, conserved 0.0042 0.04 0.1725
Schistosoma mansoni alpha glucosidase 0.0042 0.04 0.0366
Echinococcus multilocularis dna polymerase eta 0.0052 0.0527 0.0527

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 1.5 % Cell cycle arrest in human HeLa cells assessed as subG1 phase accumulation at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 1.5 % Cell cycle arrest in human HeLa cells assessed as subG1 phase accumulation at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 3.9 % Cell cycle arrest in human HeLa cells assessed as G1 phase accumulation at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 3.9 % Cell cycle arrest in human HeLa cells assessed as G1 phase accumulation at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 5.9 % Cell cycle arrest in human HeLa cells assessed as subG1 phase accumulation at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 5.9 % Cell cycle arrest in human HeLa cells assessed as subG1 phase accumulation at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 10.8 % Cell cycle arrest in human HeLa cells assessed as G1 phase accumulation at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 10.8 % Cell cycle arrest in human HeLa cells assessed as G1 phase accumulation at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 15.3 % Cell cycle arrest in human HeLa cells assessed as G2/M phase accumulation at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 15.3 % Cell cycle arrest in human HeLa cells assessed as G2/M phase accumulation at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 17.2 % Cell cycle arrest in human HeLa cells assessed as increase in DNA polyploidy at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 17.2 % Cell cycle arrest in human HeLa cells assessed as increase in DNA polyploidy at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 19.8 % Cell cycle arrest in human HeLa cells assessed as G2/M phase accumulation at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 19.8 % Cell cycle arrest in human HeLa cells assessed as G2/M phase accumulation at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 21.8 % Cell cycle arrest in human HeLa cells assessed as S phase accumulation at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 21.8 % Cell cycle arrest in human HeLa cells assessed as S phase accumulation at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 50 % Antiproliferative activity against human HeLa cells at 0.3 uM after 48 hrs by MTT assay ChEMBL. 18180162
Activity (functional) = 50 % Antiproliferative activity against human HeLa cells at 0.3 uM after 48 hrs by MTT assay ChEMBL. 18180162
Activity (functional) = 50.8 % Cell cycle arrest in human HeLa cells assessed as S phase accumulation at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 50.8 % Cell cycle arrest in human HeLa cells assessed as S phase accumulation at 0.3 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 53.2 % Cell cycle arrest in human HeLa cells assessed as increase in DNA polyploidy at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 53.2 % Cell cycle arrest in human HeLa cells assessed as increase in DNA polyploidy at 1.0 uM after 24 hrs by flow cytometry ChEMBL. 18180162
Activity (functional) = 100 % Antiproliferative activity against human HeLa cells at 1.0 uM after 48 hrs by MTT assay ChEMBL. 18180162
Activity (functional) = 100 % Antiproliferative activity against human HeLa cells at 1.0 uM after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 6.43 Cytotoxicity against human HeLa cells after 48 hrs by MTT assay ChEMBL. 20662543
GI50 (functional) = 0.37 uM Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 0.37 uM Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 0.37 uM Cytotoxicity against human HeLa cells after 48 hrs by MTT assay ChEMBL. 20662543
GI50 (functional) = 0.38 uM Antiproliferative activity against human A549 cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 0.38 uM Antiproliferative activity against human A549 cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 0.38 uM Cytotoxicity against human A549 cells after 48 hrs by MTT assay ChEMBL. 20662543
GI50 (ADMET) = 2.77 uM Cytotoxicity against human Detroit 551 cells after 48 hrs by MTT assay ChEMBL. 20662543
GI50 (functional) = 2.95 uM Antiproliferative activity against human SKHep cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 4.93 uM Antiproliferative activity against human SAS cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 4.93 uM Antiproliferative activity against human SAS cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 4.93 uM Cytotoxicity against human SAS cells after 48 hrs by MTT assay ChEMBL. 20662543
GI50 (functional) = 5.28 uM Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 5.28 uM Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 5.28 uM Cytotoxicity against human PC3 cells after 48 hrs by MTT assay ChEMBL. 20662543
GI50 (functional) = 6.84 uM Antiproliferative activity against human AGS cells after 48 hrs by MTT assay ChEMBL. 18180162
GI50 (functional) = 6.84 uM Antiproliferative activity against human AGS cells after 48 hrs by MTT assay ChEMBL. 18180162
IC50 (functional) = 0.38 uM Anticancer activity against human A549 cells after 48 hrs by MTT assay ChEMBL. 21599000
IC50 (binding) = 6.6 uM Inhibition of human topoisomerase 1 assessed as decrease in pBR322 mobility on agarose gel by electrophoresis ChEMBL. 20662543
Inhibition (binding) = 70 % Inhibition of human topoisomerase 1 assessed as decrease in pBR322 mobility on agarose gel at 10 uM by electrophoresis ChEMBL. 20662543

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 21599000

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.